PTGX logo

Protagonist Therapeutics, Inc. (PTGX) EV/EBITDA

EV/EBITDA:

233.86-10.82(-4.42%)
December 18, 2025

Summary

  • As of today, PTGX EV/EBITDA is 233.86, with a fall of -10.82 (-4.42%) during the most recent trading session on December 18, 2025.
  • Over the past year, PTGX EV/EBITDA has increased by +221.39 (+1775.38%).
  • PTGX EV/EBITDA is now -11.08% below its all-time high of 262.99.

Performance

PTGX EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherPTGXvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

PTGX EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise ValueEnterprise ValuePricePrice
1D1 Day-4.4%-4.4%-4.0%
1M1 Month+0.9%+0.9%+0.8%
3M3 Months+89.6%+44.9%+37.9%
6M6 Months+153.5%+72.6%+59.1%
YTDYTD+2969.0%+146.3%+122.3%
1Y1 Year+1775.4%+152.7%+117.0%
5Y5 Years+1986.0%+551.9%+306.2%

PTGX EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month262.99-11.1%229.01+2.1%
3M3-Month262.99-11.1%123.34+89.6%
6M6-Month262.99-11.1%91.07+156.8%
1Y1-Year262.99-11.1%6.83+3324.0%
3Y3-Year262.99-11.1%-16.97+1478.1%
5Y5-Year262.99-11.1%-27.68+944.9%
All-TimeAll-Time262.99-11.1%-27.68+944.9%

PTGX EV/EBITDA History

DateValue
2025
233.86(+2969.0%)
2024
7.62(+170.0%)
2023
-10.88(-357.1%)
2022
-2.38(+77.7%)
2021
-10.69(-13.0%)
DateValue
2020
-9.46(-836.6%)
2019
-1.01(-46.4%)
2018
-0.69(+91.4%)
2017
-8.06(+10.1%)
2016
-8.97

FAQ

  • What is Protagonist Therapeutics, Inc. EV/EBITDA?
  • What is the all-time high EV/EBITDA for Protagonist Therapeutics, Inc.?
  • What is PTGX EV/EBITDA year-to-date change?
  • What is Protagonist Therapeutics, Inc. EV/EBITDA year-on-year change?

What is Protagonist Therapeutics, Inc. EV/EBITDA?

The current EV/EBITDA of PTGX is 233.86

What is the all-time high EV/EBITDA for Protagonist Therapeutics, Inc.?

Protagonist Therapeutics, Inc. all-time high EV/EBITDA is 262.99

What is PTGX EV/EBITDA year-to-date change?

Protagonist Therapeutics, Inc. EV/EBITDA has changed by +226.24 (+2969.03%) since the beginning of the year

What is Protagonist Therapeutics, Inc. EV/EBITDA year-on-year change?

Over the past year, PTGX EV/EBITDA has changed by +221.39 (+1775.38%)
On this page